Ocean Pine Healthcare Fund

Oceanpine Healthcare Fund operates as a specialized venture fund, concentrating on early-stage healthcare companies with disruptive technologies. It invests in firms across China and the United States possessing core technologies and proprietary R&D capabilities. The fund employs a "Dual Market" strategy, effectively bridging China's R&D gap by integrating global innovation and resources.

Adam Jigang Sun, a seasoned venture capitalist, established Oceanpine Healthcare Fund around 2016. His founding insight was to connect healthcare innovations from US academic institutions and startups with market opportunities in China. This approach facilitates translating advanced research into commercially viable technologies, leveraging Sun's financial expertise.

The fund supports portfolio companies with local resources and strategic guidance for growth and market penetration. Oceanpine Healthcare Fund collaborates with prominent academic institutions like the University of Chicago and MD Anderson Cancer Center to ensure successful commercialization of research projects within China. Its vision is to be a pivotal conduit for global healthcare advancement.